Dogwood Therapeutics, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2019 | — | $-5.0M | $309.4K |
| Mar 2020 | — | — | $1.2M |
| Jun 2020 | — | — | $1.0M |
| Sep 2020 | — | — | $499.1K |
| Dec 2020 | — | $29.9M | $29.8M |
| Mar 2021 | — | $27.1M | $24.6M |
| Jun 2021 | — | $22.9M | $21.8M |
| Sep 2021 | — | $18.9M | $19.2M |
| Dec 2021 | — | $14.5M | $14.0M |
| Mar 2022 | — | $10.7M | $11.4M |
| Jun 2022 | — | $7.1M | $7.7M |
| Sep 2022 | — | $9.2M | $9.8M |
| Dec 2022 | — | $7.3M | $7.0M |
| Mar 2023 | — | $6.0M | $5.3M |
| Jun 2023 | — | $4.7M | $4.6M |
| Sep 2023 | — | $4.8M | $4.8M |
| Dec 2023 | — | $3.8M | $3.3M |
| Mar 2024 | — | $2.7M | $2.4M |
| Jun 2024 | — | $3.1M | $3.0M |
| Sep 2024 | — | $949.4K | $2.0M |
| Dec 2024 | — | $-10.1M | $14.8M |
| Mar 2025 | — | $7.1M | $17.5M |
| Jun 2025 | — | $6.9M | $13.4M |
| Sep 2025 | — | $7.3M | $10.1M |
| Dec 2025 | — | $74.9M | $6.5M |
| Mar 2026 | — | $80.6M | $13.2M |
| Jun 2026 | — | $68.4M | $9.6M |